Username
Password
Remember me on this computer
Help
Forgot your password?
BECOME A MEMBER
Get full access to theheart.org
With
full membership
, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
Join now for full access!
Get 30 days of free limited access to read heart
wire
news
Healthcare professionnal
Yes
No
Join now for limited access!
Home
Edition
EN
FR
ES
BLOGS
RADIO
ACS
Arrhythmia/EP
Brain/Kidney/Peripheral
Clinical cardiology
Heart failure
Hypertension
Imaging
Interventional/Surgery
Lipid/Metabolic
Prevention
Thrombosis
Resource Center
What's New
Abstracts
Articles
Guidelines
Slides
Program Slides
Toolbox
Supported by an independent educational grant from Bayer HealthCare.
What's New
Abstracts
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease Position Paper.
De Caterina R, Husted S, Wallentin L, et al.
J Am Coll Cardiol.
2012;59:1413-1425.
Articles
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism.
The Einstein-PE Investigators.
N Engl J Med.
2012. [Epub ahead of print]
Articles
Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study.
Hippisley-Cox J, Coupland C.
BMJ
. 2011;343:d4656.
Articles
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Labos C, Dasgupta K, Nedjar H, et al.
CMAJ.
2011;183:1835-1843.
Articles
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.
Goldhaber SZ, Leizorovicz A, Kakkar AK, et al.
N Engl J Med.
2011;365:2167-2177.
Abstracts
How to prevent, treat, and overcome current clinical challenges of VTE.
Van Es J, Eerenberg ES, Kamphuisen PW, et al.
J Thromb Haemost.
2011;9(Suppl 1):265-274.
Abstracts
Apixaban with antiplatelet therapy after acute coronary syndrome.
Alexander JH, Lopes RD, James S, et al.
N Engl J Med.
2011;365:699-708.
Abstracts
Desirudin: a review of the pharmacology and clinical application for the prevention of deep vein thrombosis.
Graetz TJ, Tellor BR, Smith JR, et al.
Expert Rev Cardiovasc Ther.
2011;9:1101-1109.
Abstracts
Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation.
Poli D, Antonucci E, Testa S, et al.
Circulation.
2011;124:824-829.
Abstracts
Apixaban versus warfarin in patients with atrial fibrillation.
Granger CB, Alexander JH, McMurray JJ, et al.
N Engl J Med.
2011;365:981-992.